Clozapine is associated with secondary antibody deficiency

BACKGROUND: Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia. Clozapine is also associated with increased risk of pneumonia although the mechanism is poorly unders...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Br J Psychiatry
Autores principales: Ponsford, Mark, Castle, Daniel, Tahir, Tayyeb, Robinson, Rebecca, Wade, Wendy, Steven, Rachael, Bramhall, Kathryn, Moody, Mo, Carne, Emily, Ford, Catherine, Farewell, Daniel, Williams, Paul, El-Shanawany, Tariq, Jolles, Stephen
Formato: Artigo
Lenguaje:Inglês
Publicado: Cambridge University Press 2019
Materias:
Papers
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6429246/
https://ncbi.nlm.nih.gov/pubmed/30259827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/bjp.2018.152
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares